Back
rt D
RTDR
Aarti Drugs Ltd
(AARTIDRUGS)
Follow
FY2025 Announcement
View More
Back
rt D
RTDR
Aarti Drugs Ltd
(AARTIDRUGS)
Follow
FY2025 Announcement
Filing:
Announcement
Published on:
3 Feb '25
Announcements
Financial Results Published
8 May '25
Conference Call Recording
7 May '25
Court Order Update
7 May '25
Investor Presentation
6 May '25
Q4 FY25 Performance
6 May '25
Earnings Call Scheduled
29 Apr '25
Compliance Certificate
8 Apr '25
Cautionary Letter
2 Apr '25
Investor Meetings
17 Mar '25
Meeting Cancellation
11 Mar '25
Regulatory Warning
7 Mar '25
SEBI Warning Letter
6 Mar '25
ESG Rating Update
3 Mar '25
Investor Meetings
28 Feb '25
Import Alert Lifted
14 Feb '25
CGST Regulatory Order
7 Feb '25
Bank Account Restored
5 Feb '25
Earnings Call Transcript
4 Feb '25
Equity Acquisition
4 Feb '25
Acquisition Announcement
3 Feb '25
Financial Results Publication
31 Jan '25
Credit Rating Update
31 Jan '25
Conference Call Recording
30 Jan '25
Investor Presentation
29 Jan '25
Q3 FY25 Results
29 Jan '25
Investment in Pinnacle
29 Jan '25
Bank Account Attachment
28 Jan '25
Earnings Conference Call
23 Jan '25
New Acquisition
9 Jan '25
Compliance Certificate
7 Jan '25
FDA Inspection Complete
24 Dec '24
New Subsidiary Created
27 Nov '24
Manufacturing Restoration
16 Nov '24
Meeting Cancellation
14 Nov '24
Investor Meetings
13 Nov '24
Investor Meeting
13 Nov '24
Earnings Call Transcript
2 Nov '24
Credit Rating Reaffirmed
30 Oct '24
Financial Results Publication
26 Oct '24
Conference Call Update
25 Oct '24
Investor Presentation
24 Oct '24
Financial Results Decline
24 Oct '24
Earnings Call Notice
17 Oct '24
Compliance Certificate
9 Oct '24
Regulatory Compliance
9 Oct '24
GMP Certification Received
3 Oct '24
Share Buyback Completed
27 Sep '24
Post Buyback Announcement
26 Sep '24
Share Buyback
26 Sep '24
FDA Inspection Update
25 Sep '24
FDA Inspection Results
20 Sep '24
Directorate Changes
20 Sep '24
Shareholder Presentation
20 Sep '24
Buyback Extension
17 Sep '24
Buyback Extension
17 Sep '24
Buyback Extension
16 Sep '24
Investor Meeting
12 Sep '24
Buyback Announcement
10 Sep '24
Open Offer Update
10 Sep '24
Buyback Announcement
9 Sep '24
Buyback Announcement
9 Sep '24
Annual Meeting Notice
30 Aug '24
Investor Meeting
29 Aug '24
AGM Notice
28 Aug '24
Share Buyback
28 Aug '24
Share Buyback Announcement
28 Aug '24
Buyback Offer
28 Aug '24
Share Buyback Plan
26 Aug '24
Conditional Restart Directions
7 Aug '24
Earnings Call Transcript
5 Aug '24
Show Cause Notice
3 Aug '24
US FDA EIR Announcement
1 Aug '24
FDA EIR Receipt
29 Jul '24
Conference Call Recording U...
29 Jul '24
Financial Results Publication
29 Jul '24
Investor Presentation
26 Jul '24
Financial Results Press Rel...
26 Jul '24
Change in Director
26 Jul '24
Earnings Conference Call
19 Jul '24
Closure Announcement
17 Jul '24
Certificate Submission
10 Jul '24
Fire Incident Update
9 Jul '24
TV Interview
20 Jun '24
Fire Incident
18 Jun '24
Compliance Report Submission
23 May '24
Investor Conference
22 May '24
Newspaper Publication
15 May '24
Earnings Calls
10 May '24
Conference Call Outcome
6 May '24
Financial Results
4 May '24
Investor Presentation
4 May '24
Financial Results Decline
3 May '24
Conference Call Rescheduling
30 Apr '24
Conference Call
29 Apr '24
FDA Inspection Results
23 Apr '24
Certificate Submission
19 Apr '24
Compliance Certificate Subm...
5 Apr '24
Certificate Submission
3 Apr '24
Committee Reconstitution
30 Mar '24
Appointment Of Independent ...
29 Mar '24
Retirement
29 Mar '24
Directorate Change
29 Mar '24
Investor Conference
21 Mar '24
Gujarat Plant Revocation
20 Mar '24
Credit Rating Affirmed
29 Feb '24
Transcript Released
1 Feb '24
Product Launch
30 Jan '24
Conference Call Recording U...
25 Jan '24
Financial Results Publication
25 Jan '24
Investor Presentation
24 Jan '24
Financial Results
24 Jan '24
Earnings Conference Call
19 Jan '24
Compliances-Certificate Reg...
9 Jan '24
Certificate Under Regulatio...
9 Jan '24
Warning Letter Received
28 Dec '23
Cancellation
22 Nov '23
Investors Conference
16 Nov '23
Investor Conference
2 Nov '23
Transcript Release
27 Oct '23
Financial Results Publication
23 Oct '23
Conference Call Recording U...
20 Oct '23
Related Party Transactions ...
19 Oct '23
Investor Presentation
19 Oct '23
Financial Results
19 Oct '23
Earnings Conference Call
16 Oct '23
Certificate Submission
10 Oct '23
Shareholder Presentation
26 Sep '23
Analyst Meet
20 Sep '23
Credit Rating Reaffirmed
15 Sep '23
Analyst Meet
15 Sep '23
Advertisement Publication
3 Sep '23
Buyback Completion
1 Sep '23
Newspaper advertisement
1 Sep '23
Analyst Meet
31 Aug '23
Public Announcement
28 Aug '23
Buyback completion
28 Aug '23
Rights Offerings
8 Aug '23
Stock Buybacks
7 Aug '23
Earnings Calls
28 Jul '23
Stock Buybacks
25 Jul '23
Stock Buybacks
25 Jul '23
Conference Call
24 Jul '23
Financial Statements
24 Jul '23
Stock Buybacks
21 Jul '23
Financial Statements
21 Jul '23
FinancialStatements
21 Jul '23
Stock Buybacks
21 Jul '23
Conference Call
18 Jul '23
Reply to Clarification
13 Jul '23
Certificate Submission
10 Jul '23
Awards
6 Jul '23
Analyst Meet
15 Jun '23
Compliance with SEBI (LODR)...
2 Jun '23
Management Changes
26 May '23
Earnings Call Transcript
7 May '23
Financial Results Publication
2 May '23
Conference Call
2 May '23
Results Presentation
2 May '23
External Links:
BSE
NSE
Data:
Download
AI Assistant
Close
Aarti Drugs Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.
AARTIDRUGS Aarti Drugs Ltd Company Mergers Announcement